About Us Strategy & Mission Our Values Our People Our Board Our Scientific Advisors Our Collaborations Contact Our Programs Pipeline C. difficile Infection Enterobacteriaceae Clinical Trials Innovation Engine New Era Microbiome Therapeutics Discuva Platform Scientific Literature & Publications Investors & Media Investor Center Media Center Press Releases Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Shareholder Meetings Summit Presentations Careers
Resistance Development Studies With Ridinilazole (RDZ) and Clostridium difficile Resistance Development Studies With Ridinilazole (RDZ) and Clostridium difficile June 20, 2016 By CKD Digital
Resistance Development Studies With Ridinilazole (RDZ) and Clostridium difficile June 20, 2016 By CKD Digital
